Stay updated on Nivolumab in Refractory Biliary Tract Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.

Latest updates to the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page
- Check4 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a small template or system update for the study page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4. This indicates a minor update to the study page metadata without changing its content.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedFooter now includes references to the Moffitt Clinical Trials website and sponsor organization, plus a 'Helpful Links Provided by' attribution. The revision tag has been updated from v3.6.2 to v3.6.3.SummaryDifference0.2%

- Check47 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2. This indicates a newer page build without changes to the study content or data.SummaryDifference0.1%

- Check62 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', and new help sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added to assist users. The Intervention/Treatment header was reformatted to 'Intervention / Treatment' and the revision label updated to v3.6.0.SummaryDifference0.5%

- Check69 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a newer version of the page. This typically reflects minor updates or fixes applied to the page content or documentation.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Refractory Biliary Tract Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.